NASDAQ:MBIO
Mustang Bio, Inc.
Mustang Bio, Inc. reported net income of −$1.9M in fiscal 2025. The diluted share count rose 705.0%.Summary generated from Mustang Bio, Inc.'s SEC filings. Latest annual report filed Mar 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−67.9%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+705.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −67 | −76 | −49 | −16 | −2 |
| Net income | −66 | −78 | −52 | −16 | −2 |
| Free cash flow | −58 | −68 | −50 | −11 | n/a |
Recent filings
- 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026 - 4Insider transaction report
Apr 27, 2026 - 8-KNotice of delisting or listing-rule failure
Apr 17, 2026 - 10-KAnnual report for the fiscal year ended Dec 31, 2025
Mar 19, 2026 - 4Insider transaction report
Jan 5, 2026 - 8-KResults of a shareholder vote
Dec 23, 2025 - DEF 14AProxy statement
Dec 3, 2025